Supha Pharmachem Limited (BOM:539561)

Market Cap	116.93M -84.1%
Revenue (ttm)	5.27B -84.3%
Net Income	122.54M -49.2%
EPS	0.19 -53.8%
Shares Out	403.20M
PE Ratio	1.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,077,881
Open	0.2900
Previous Close	0.2800
Day's Range	0.2900 - 0.2900
52-Week Range	0.2500 - 1.8000
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Supha Pharmachem

Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium meta...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In fiscal year 2025, Supha Pharmachem's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 22, 2026

Data Sources Report a data error